Skip to main content

PhaseBio Pharmaceuticals Inc

PHASDelisted Dec 21, 2022
Industry
Pharmaceutical Preparations
SEC CIK
0001169245

PhaseBio Pharmaceuticals Inc was delisted on Dec 21, 2022; its insiders filed their last Form 4 on May 19, 2023; 39 institutions reported holding it in 13F filings for Q3 2022, worth $3.90M in total; no superinvestor held it.

13F holders, Q2 2022

Institutional positions in PhaseBio Pharmaceuticals Inc as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
50
−7 vs. Q1 2022
Shares held
23.4M
−6.00M (−20.4%) vs. Q1 2022
Total value
$14.1M
−$24.8M (−63.8%) vs. Q1 2022
New holders
6
12 more added
Sold out
13
13 more reduced

Compare with Q1 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting PHAS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2022: 50 institutions
Q1 2021: 62 institutionsQ2 2021: 56 institutionsQ3 2021: 62 institutionsQ4 2021: 52 institutionsQ1 2022: 57 institutionsQ2 2022: 50 institutionsQ3 2022: 39 institutionsQ4 2022: 5 institutionsQ1 2023: 0 institutionsQ2 2023: 0 institutionsQ3 2023: 0 institutionsQ4 2023: 0 institutionsQ1 2024: 0 institutionsQ2 2024: 0 institutionsQ3 2024: 0 institutionsQ4 2024: 0 institutionsQ1 2025: 0 institutionsQ2 2025: 0 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ2 2022: $14.1M
Q1 2021: $110.3MQ2 2021: $113.3MQ3 2021: $95.9MQ4 2021: $73.5MQ1 2022: $38.8MQ2 2022: $14.1MQ3 2022: $3.90MQ4 2022: $15.6KQ1 2023: $0Q2 2023: $0Q3 2023: $0Q4 2023: $0Q1 2024: $0Q2 2024: $0Q3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding PHAS and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20250$0
Q1 20250$0
Q4 20240$0
Q3 20240$0
Q2 20240$0
Q1 20240$0
Q4 20230$0
Q3 20230$0
Q2 20230$0
Q1 20230$0
Q4 20225$15.6K
Q3 202239$3.90M
Q2 202250$14.1M
Q1 202257$38.8M
Q4 202152$73.5M
Q3 202162$95.9M
Q2 202156$113.3M
Q1 202162$110.3M

Institutions, Q2 2022

Shares, value and share of portfolio for each institution holding PhaseBio Pharmaceuticals Inc; share changes are against Q1 2022.

Institutions holding PHAS in Q2 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Barclays PLC197$00.00%−31,698−99.4%Reduced
Curi Capital823$00.00%−3,247−79.8%Reduced
JPMorgan Chase & Co17$00.00%−2,000−99.2%Reduced
Cutler Group LP1,000$00.00%00.0%Unchanged
Bank of America Corp193$00.00%+192+19,200.0%Added
Kistler-Tiffany Companies, LLC300$00.00%00.0%Unchanged
BNP Paribas Arbitrage, SA79$470.00%00.0%Unchanged
TD Waterhouse Canada Inc.850$6930.00%00.0%Unchanged
Royal Bank of Canada2,000$1.00K0.00%00.0%Unchanged
Wells Fargo & Company1,807$1.00K0.00%+21+1.2%Added
Harbour Investments, Inc.3,600$2.00K0.00%+3,600New
Toronto Dominion Bank4,670$3.00K0.00%−980−17.3%Reduced
Advisor Group Holdings, Inc.3,825$3.00K0.00%00.0%Unchanged
Citigroup Inc6,000$4.00K0.00%+6,000New
UBS Group AG9,830$6.00K0.00%+8,248+521.4%Added
Millennium Management LLC13,501$8.00K0.00%−77,208−85.1%Reduced
Two Sigma Advisers, LP12,700$8.00K0.00%−17,400−57.8%Reduced
Two Sigma Securities, LLC12,845$8.00K0.00%−8,634−40.2%Reduced
Raymond James & Associates15,500$9.00K0.00%00.0%Unchanged
Resources Investment Advisors, LLC.16,150$10.0K0.00%−97,000−85.7%Reduced
Tower Research Capital LLC (TRC)25,203$15.0K0.00%+24,950+9,861.7%Added
United Bank26,900$16.0K0.00%00.0%Unchanged
IPG Investment Advisors LLC28,900$17.0K0.00%00.0%Unchanged
Virtu Financial LLC31,852$19.0K0.00%+547+1.7%Added
Blair William & Co35,696$21.0K0.00%00.0%Unchanged
Hamilton Lane Advisors LLC34,208$21.0K0.01%00.0%Unchanged
Northeast Financial Consultants Inc37,760$23.0K0.00%00.0%Unchanged
Prudential Financial Inc44,100$26.0K0.00%+44,100New
Northern Trust Corp58,119$35.0K0.00%00.0%Unchanged
Snowden Capital Advisors LLC60,800$36.0K0.00%+9,000+17.4%Added
State Street Corp91,850$55.0K0.00%+4,000+4.6%Added
Morgan Stanley106,766$64.0K0.00%−34,102−24.2%Reduced
Citadel Advisors LLC107,953$65.0K0.00%+107,953New
Jane Street Group, LLC112,668$68.0K0.00%+112,668New
Marshall Wace, LLP123,039$73.0K0.00%−98,444−44.4%Reduced
Bridgeway Capital Management, LLC126,600$76.0K0.00%−160,000−55.8%Reduced
New Legacy Group, LLC240,575$144.0K0.29%00.0%Unchanged
Platform Technology Partners242,900$146.0K0.08%+427+0.2%Added
Acadian Asset Management LLC272,770$164.0K0.00%−52,490−16.1%Reduced
Geode Capital Management, LLC320,642$192.0K0.00%00.0%Unchanged
DAFNA Capital Management LLC378,611$227.0K0.06%00.0%Unchanged
Stifel Financial Corp439,265$264.0K0.00%+147,267+50.4%Added
BlackRock Inc.684,204$411.0K0.00%+2,713+0.4%Added
CHI Advisors LLC750,000$450.0K0.17%+750,000New
Johnson & Johnson1,607,044$964.0K0.25%00.0%Unchanged
MAI Capital Management1,709,104$1.02M0.02%+290,825+20.5%Added
Vanguard Group Inc1,808,098$1.08M0.00%−18,033−1.0%Reduced
Rock Springs Capital Management LP2,774,869$1.67M0.05%+161,044+6.2%Added
Avidity Partners Management LP4,405,000$2.64M0.06%00.0%Unchanged
NEA Management Company, LLC6,643,702$3.99M0.20%00.0%Unchanged
Ra Capital Management, L.P.0$00.00%−2,850,000−100.0%Sold out
Wellington Management Group LLP0$00.00%−1,674,690−100.0%Sold out
Towercrest Capital Management0$00.00%−1,051,940−100.0%Sold out
Vericrest Private Wealth0$00.00%−1,051,940−100.0%Sold out
Endurant Capital Management LP0$00.00%−243,795−100.0%Sold out
Renaissance Technologies LLC0$00.00%−89,300−100.0%Sold out
Occudo Quantitative Strategies LP0$00.00%−33,808−100.0%Sold out
Schonfeld Strategic Advisors LLC0$00.00%−25,500−100.0%Sold out
Cubist Systematic Strategies, LLC0$00.00%−20,143−100.0%Sold out
ETF Managers Group, LLC0$00.00%−14,587−100.0%Sold out
Spire Wealth Management0$00.00%−8,000−100.0%Sold out
Capital Advisory Group Advisory Services, LLC0$00.00%−2,800−100.0%Sold out
Simplex Trading, LLC0$00.00%−927−100.0%Sold out